‹
›
This content requires a premium subscription.
Please
log in
or
subscribe
to continue.
Journal of Clinical Oncology (JCO) Podcast
HERA Indicates that Adjuvant Trastuzumab Confers Equal Benefit for HER2-Positive Invasive Ductal and Invasive Lobular Breast Cancers
30
00:00:00
/ 00:10:33
30